Skip to main content

Market Overview

38 Stocks Moving In Tuesday's Mid-Day Session



  • Biocept, Inc. (NASDAQ: BIOC) shares rose 73.6 percent to $1.19 after the company entered a software license and laboratory data supply agreement with Prognos.
  • Marin Software Incorporated (NASDAQ: MRIN) shares climbed 37.8 percent to $3.94 after the company announced it has entered a revenue sharing agreement with Google. The company also raised Q4 guidance.
  • Navistar International Corporation (NYSE: NAV) rose 17.8 percent to $28.08 after the company reported better-than-expected results for its fourth quarter.
  • ReShape Lifesciences Inc. (NASDAQ: RSLS) gained 15.5 percent to $0.4750 after the company acquired Apollo Endosurgery's lap-band system.
  • Kodiak Sciences Inc. (NASDAQ: KOD) shares climbed 15.3 percent to $7.68.
  • CollPlant Holdings Ltd. (NASDAQ: CLGN) shares gained 14.2 percent to $4.98.
  • Materialise NV (NASDAQ: MTLS) shares climbed 12.9 percent to $17.82.
  • Limbach Holdings, Inc. (NASDAQ: LMB) gained 12.1 percent to $3.99.
  • The Meet Group, Inc. (NASDAQ: MEET) rose 11.3 percent to $3.7511. The Meet Group reported that annualized video revenue run-rate rose to $62 million in November, up from $55 million in October.
  • Tyme Technologies, Inc. (NASDAQ: TYME) gained 10.5 percent to $3.58.
  • NRC Group Holdings Corp. (NASDAQ: NRCG) climbed 9.4 percent to $9.31.
  • SMART Global Holdings, Inc. (NASDAQ: SGH) rose 9.2 percent to $30.65. SMART Global will replace XO Group in the S&P SmallCap 600 on Monday, December 24.
  • Tilray, Inc. (NASDAQ: TLRY) climbed 8.1 percent to $71.20 after the company announced a partnership with German pharmaceutical company Sandoz to distribute non-smokable medical cannabis products.
  • Boot Barn Holdings, Inc. (NYSE: BOOT) climbed 7.6 percent to $17.12.
  • Scientific Games Corporation (NASDAQ: SGMS) shares rose 7.5 percent to $17.05.
  • Cellect Biotechnology Ltd. (NASDAQ: APOP) shares gained 6.8 percent to $2.67.
  • HealthEquity, Inc. (NASDAQ: HQY) gained 6.6 percent to $63.59. Cantor Fitzgerald upgraded Healthequity from Neutral to Overweight.
  • HEICO Corporation (NYSE: HEI) climbed 5.9 percent to $82.44 after the company beat Q4 EPS and sales estimates.
  • FibroGen, Inc. (NASDAQ: FGEN) rose 5.6 percent to $41.17 after the company said its China unit has received marketing authorization from the National Medical Products Administration for Roxadustat, a hypoxia-inducible factor propyl hydroxylase inhibitor for treating patients with anemia caused by chronic kidney disease, who are dialysis dependent.
  • NCR Corporation (NYSE: NCR) shares gained 5.3 percent to $23.90. RBC Capital upgraded NCR from Outperform to Top Pick.
  • Puma Biotechnology, Inc. (NASDAQ: PBYI) rose 5 percent to $22.48 after the company reported favorable results from its Phase III NALA trial of Neratinib in breast cancer patients.


Check out these big penny stock gainers and losers


  • Nemaura Medical Inc. (NASDAQ: NMRD) shares tumbled 39.2 percent to $0.8450 after the company priced its $2.5 million share common stock offering at $1.02 per share.
  • Champions Oncology, Inc. (NASDAQ: CSBR) shares declined 18.4 percent to $7.79. Champions Oncology reported Q2 revenues of $6.7 million, up 28.6 percent year-over-year, and non-GAAP EPS of 3 cents compared to break-even results a year ago.
  • Diffusion Pharmaceuticals Inc. (NASDAQ: DFFN) dipped 17.4 percent to $2.33.
  • OptimizeRx Corporation (NASDAQ: OPRX) dipped 16.8 percent to $9.65 after the company priced its offering of approximately 2.1 million shares at $10 per share.
  • Dova Pharmaceuticals, Inc. (NASDAQ: DOVA) shares fell 16.3 percent to $7.54.
  • Cancer Genetics, Inc. (NASDAQ: CGIX) dipped 15.9 percent to $0.2800 on continued weakness after the company on Monday announced it has terminated its proposed merger with NovellusDx.
  • Motus GI Holdings, Inc. (NASDAQ: MOTS) shares dropped 15.8 percent to $2.6942 after reporting a proposed 5 million share follow-on offering of common stock.
  • Rent-A-Center, Inc. (NASDAQ: RCII) fell 15.6 percent to $12.19 after terminating its merger agreement with Vintage Capital.
  • Achillion Pharmaceuticals, Inc. (NASDAQ: ACHN) shares dropped 14.8 percent to $2.0450 after the company reported positive interim Phase 2 trials of its first-gen oral factor D inhibitor ACH-4471, as well as pharmacokinetics and potency data for its next-gen factor D inhibitors ACH-5228 and ACH-5548.
  • Evofem Biosciences, Inc. (NASDAQ: EVFM) fell 14.3 percent to $3.4700 after climbing 15.71 percent on Monday.
  • NF Energy Saving Corporation (NASDAQ: NFEC) dropped 12.4 percent to $9.35.
  • Worthington Industries, Inc. (NYSE: WOR) shares fell 10.9 percent to $32.67 after the company posted downbeat Q2 results.
  • Integrated Media Technology Limited (NASDAQ: IMTE) dropped 9.1 percent to $4.41.
  • Eyenovia, Inc. (NASDAQ: EYEN) shares tumbled 8.7 percent to $2.83.
  • RiceBran Technologies (NASDAQ: RIBT) dipped 7.4 percent to $3.11.
  • Washington Prime Group Inc. (NYSE: WPG) fell 7.2 percent to $5.36 after dropping 6.18 percent on Monday. Goldman Sachs downgraded Washington Prime Group from Neutral to Sell.
  • Comstock Resources, Inc. (NYSE: CRK) dropped 6.6 percent to $4.68.

Related Articles (ACHN + APOP)

View Comments and Join the Discussion!

Posted-In: LosersNews Movers & Shakers Intraday Update Markets Movers Trading Ideas General

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at